AA 10023
Alternative Names: AA10023Latest Information Update: 21 Nov 2006
At a glance
- Originator Arachnova
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 21 Nov 2006 Discontinued - Preclinical for Neurological disorders in United Kingdom (unspecified route)
- 07 May 2003 Preclinical trials in Neurological disorders in United Kingdom (unspecified route)